Tuesday, March 03, 2015 1:19:50 PM
Business Wire
CLARENCE, N.Y. -- March 3, 2015
The Board of Directors of 22nd Century Group, Inc. (NYSE MKT:XXII) announced today that Henry Sicignano III has been named to the position of Chief Executive Officer. Mr. Sicignano will continue to serve as the Company’s President and will remain on the Board of Directors.
“The Board of Directors has had the opportunity to work directly with Henry over the past few months and is convinced that there is no better person to lead the company forward,” said James W. Cornell, Chairman of the Board of Directors. “Henry is a proven leader with outstanding business development skills, strategic vision and the ability to bring people together. His vision for how 22nd Century will monetize the Company’s proprietary technologies is exactly what 22nd Century needs at this exciting stage in the Company’s growth.”
Since joining the Company as President in 2010, Mr. Sicignano has spearheaded major initiatives across a range of business areas, recently establishing a strategic partnership with Smoker Friendly International, the nation’s largest dealer network of cigarette stores, and securing contract manufacturing and distribution agreements to launch the Company’s MAGIC® brand of cigarettes in Europe. Going forward, Mr. Sicignano has defined 22nd Century’s top priorities as: establishing multi-year international sales contracts for the Company’s proprietary tobacco products (with immediate focus on Asia); submitting to the FDA a Modified Risk Application for the Company’s Brand A very low nicotine cigarettes; and identifying a joint venture partner to fund Phase III clinical trials for X-22, the Company’s smoking cessation aid in development.
“22nd Century is in the rare position of having a virtual monopoly around the nicotine biosynthetic pathway in the tobacco plant; I am honored and tremendously excited to have been chosen to lead the Company as we begin to commercialize our extraordinary IP portfolio,” Mr. Sicignano said. “As the tobacco industry begins a true paradigm shift toward the development and commercialization of reduced-risk tobacco products, 22nd Century is uniquely positioned to become a key player in both the smoking harm reduction and the smoking cessation markets. A key part of my job will be to seize these opportunities by focusing our management team and the Company’s business development investments on our technology’s most important commercial applications.”
Recent XXII News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:30:52 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 09:10:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 09:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 01:30:13 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/24/2024 09:31:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/24/2024 09:30:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 01:04:11 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 10:02:41 PM
- 22nd Century Secures $3.2 Million to Date in Warrant Exchange Transaction • GlobeNewswire Inc. • 12/04/2023 12:07:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 12/01/2023 10:18:00 PM
- Pharma Stock Up Big After Second Major Announcement This Week • AllPennyStocks.com • 11/29/2023 03:55:00 PM
- Pharma Stock Up Big After Second Major Announcement This Week • AllPennyStocks.com • 11/29/2023 03:55:00 PM
- 22nd Century Appoints Larry Firestone as Chairman and CEO • GlobeNewswire Inc. • 11/29/2023 12:07:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/27/2023 09:56:49 PM
- 22nd Century Group Enters into Agreement to Sell Hemp/Cannabis Franchise • GlobeNewswire Inc. • 11/27/2023 09:44:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 11:01:36 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 10:19:32 PM
- 22nd Century Group Continues VLN® Expansion, Now Retailing in More Than 5,100 Stores • GlobeNewswire Inc. • 11/08/2023 06:15:00 PM
- 22nd Century Group (XXII) Expands Reduced Nicotine Content Tobacco IP with Latest Technology License • GlobeNewswire Inc. • 11/07/2023 01:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2023 12:30:19 PM
- 22nd Century Group (XXII) Reports Third Quarter 2023 Financial Results • GlobeNewswire Inc. • 11/06/2023 12:30:00 PM
- 22nd Century Group (XXII) Supports FDA Policy Advancements, Proposed Menthol Ban Now at OMB • GlobeNewswire Inc. • 10/26/2023 12:30:00 PM
- 22nd Century Group (XXII) Reduces Debt by $8.1 Million • GlobeNewswire Inc. • 10/25/2023 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/18/2023 08:34:05 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM